Develops drugs for autoimmune and infectious diseases.
Jun 2026Revenue $13.6K/yrExpenses $13.8M/yr
No trendCash runway ≈ 4 months from Jun 2026
Figures by year
When will Ainos be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $13.6K and expenses $13.8M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $124K | $14.1M | −$14.0M |
| Dec 2024 | $20.7K | $13.9M | −$13.8M |
| Dec 2023 | $122K | $13.3M | −$13.2M |
| Dec 2022 | $3.52M | $17.5M | −$14.0M |
| Dec 2021 | $595K | $4.46M | −$3.87M |
| Dec 2020 | $16.6K | $1.46M | −$1.44M |
| Dec 2019 | $11.7K | $1.59M | −$1.58M |
| Dec 2018 | $77.7K | $1.41M | −$1.33M |
| Dec 2017 | $251K | $831K | −$580K |
| Dec 2015 | $0.00 | $520K | −$520K |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.